University of Montreal: Canadian First - Allogeneic CAR-T Cells to Treat Autoimmune Diseases
May 26, 2026
May 26, 2026
MONTREAL, Quebec, May 26 -- The University of Montreal issued the following news:
* * *
A Canadian first: Allogeneic CAR-T cells to treat autoimmune Diseases
HMR is launching a clinical trial on allogeneic CAR T-cell therapy to treat refractory autoimmune diseases such as lupus, myositis and scleroderma.
*
This month at Hopital Maisonneuve-Rosemont (HMR), a first patient has received an allogeneic CAR-T therapy as part of an inter . . .
* * *
A Canadian first: Allogeneic CAR-T cells to treat autoimmune Diseases
HMR is launching a clinical trial on allogeneic CAR T-cell therapy to treat refractory autoimmune diseases such as lupus, myositis and scleroderma.
*
This month at Hopital Maisonneuve-Rosemont (HMR), a first patient has received an allogeneic CAR-T therapy as part of an inter . . .